Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis

INTRODUCTION: Eosinophilic granulomatosis with polyangiitis (EGPA) is a subset of antineutrophil cytoplasmic antibodies (ANCA) associated vasculitis with distinct pathophysiological mechanisms, clinical features and treatment responses. Rituximab is a licensed therapy for granulomatosis with polyang...

Descripción completa

Detalles Bibliográficos
Autores principales: Teixeira, Vítor, Mohammad, Aladdin J, Jones, Rachel B, Smith, Rona, Jayne, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Vasculitis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560673/
https://www.ncbi.nlm.nih.gov/pubmed/31245051
http://dx.doi.org/10.1136/rmdopen-2019-000905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560673/
https://www.ncbi.nlm.nih.gov/pubmed/31245051
http://dx.doi.org/10.1136/rmdopen-2019-000905

Ejemplares similares